MedPath

杭州安元生物医药科技有限公司

Ownership
-
Established
2016-08-12
Employees
-
Market Cap
-
Website
https://www.anprimepharm.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

3

NMPA:3

Drug Approvals

Lanthanum Carbonate Chewable Tablets

Product Name
碳酸镧咀嚼片
Approval Number
国药准字H20253619
Approval Date
Mar 11, 2025
NMPA

Sevelamer Carbonate for Suspension

Product Name
碳酸司维拉姆干混悬剂
Approval Number
国药准字H20243078
Approval Date
Jan 23, 2024
NMPA

Sevelamer Carbonate for Suspension

Product Name
碳酸司维拉姆干混悬剂
Approval Number
国药准字H20243077
Approval Date
Jan 23, 2024
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.